Transcat buys Southeastern Biomedical for $12.8 million cash

PUBT · 4d ago
Transcat buys Southeastern Biomedical for $12.8 million cash
  • Transcat acquired Southeastern Biomedical Associates, expanding its biomedical calibration and compliance services footprint across the southeastern US.
  • Deal closed Aug. 31, 2026, for USD 12.8 million in cash, subject to customary adjustments and holdbacks.
  • Southeastern, founded in 1996, is based in Granite Falls, North Carolina, serving hospital networks and healthcare facilities.
  • Transaction adds regulated healthcare capabilities aligned with ISO/IEC 17025 and ISO 9001 service standards.
  • Acquisition supports Transcat’s strategy to build scale in high cost-of-failure, regulated end markets tied to patient safety and compliance.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transcat Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260831256956) on August 31, 2026, and is solely responsible for the information contained therein.